|
2024
|
Invention
|
Monospecific and bispecific antibodies and antigen binding fragments thereof.
Isolated monospeci... |
|
2022
|
Invention
|
Monospecific and bispecific antibodies and antigen binding fragments thereof. |
|
2021
|
Invention
|
Monospecific and bispecific antibodies and antigen binding fragments thereof. Isolated monospecif... |
|
2019
|
Invention
|
Methods of treating ocular diseases. A method of treating a complement mediated ocular inflammati... |
|
2018
|
Invention
|
Methods of treating hemolytic disorders comprising administering an anti-c3b antibody. A method o... |
|
2017
|
Invention
|
Aglycosylated anti-c3b antibodies and uses thereof. An aglycosylated humanized anti-C3b (AAC3b) a... |
|
|
Invention
|
Aglycosylated anti-bb antibodies and uses thereof. An aglycosylated humanized anti-Bb (AAfBb) ant... |
|
2016
|
Invention
|
Aglycosylated anti-bb antibodies and uses thereof.
An aglycosylated humanized anti-Bb (AAfBb) an... |
|
|
Invention
|
Aglycosylated anti-c3b antibodies and uses thereof.
An aglycosylated humanized anti-C3b (AAC3b) ... |
|
2015
|
Invention
|
Formulation of aglycosylated therapeutic antibodies.
Described herein are antibody formulations ... |
|
|
Invention
|
Formulation of aglycosylated therapeutic antibodies. Described herein are antibody formulations i... |
|
|
Invention
|
Method of inhibiting complement activation with human anti-factor c3 antibodies and uses thereof.... |
|
|
Invention
|
Alternative pathway specific antibodies for treating arthritis.
A method of selecting a genus of... |
|
|
Invention
|
Methods of treating hemolytic disorders comprising administering anti-bb antibodies. A method of ... |
|
|
Invention
|
Anti-factor bb antibodies. A pharmaceutical composition includes an isolated anti-Bb antibody or ... |
|
|
Invention
|
Method for treating inflammatory conditions.
A method for treating an autoimmune disease in a su... |
|
|
Invention
|
Neo antibodies for diagnostic imaging of tissue injury. A method for diagnosing the development o... |
|
2014
|
Invention
|
Compositions and methods of treating ocular diseases. A method of treating a complement mediated ... |
|
|
Invention
|
Anti-properdin antibodies. A method of inhibiting alternative complement pathway activation in a ... |
|
|
Invention
|
Methods and compositions for inhibiting cellular proliferation and surgical adhesion. The present... |
|
|
Invention
|
Humanized and chimeric anti-properdin antibodies.
An isolated anti-properdin antibody or antigen... |
|
2013
|
Invention
|
Methods of treating a hemolytic disorder comprising administering anti-properdin antibodies. A me... |
|
|
Invention
|
Alternative pathway specific antibodies for treating hemolytic diseases. A method of treating a h... |
|
|
Invention
|
Humanized and chimeric anti-factor bb antibodies and uses thereof. A method of inhibiting complem... |
|
|
Invention
|
Humanized anti-factor c3b antibodies and uses thereof. A method of inhibiting complement activati... |
|
|
Invention
|
Humanized and chimeric anti-factor c3 antibodies and uses thereof. A method of inhibiting complem... |
|
|
Invention
|
Anti-properdin antibodies.
A method of inhibiting alternative complement pathway activation in a... |
|
2012
|
Invention
|
Aglycosylated anti-properdin antibodies. The invention is a method for reducing the effector func... |
|
|
Invention
|
Aglycosylated human antibody and fusion protein and uses thereof. The invention is a method for r... |
|
|
Invention
|
Alternative pathway specific antibodies for treating arthritis. A method of selecting a genus of ... |
|
|
Invention
|
Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof.
... |
|
|
Invention
|
Method of inhibiting coagulation activation with human anti-factor v antibodies and use thereof. ... |
|
2011
|
Invention
|
Neoantibodies for diagnosing tissue injury. A method for diagnosing the development of a tissue i... |
|
|
Invention
|
Humanized and chimeric anti-properdin antibodies. An isolated anti-properdin antibody or antigen ... |
|
|
Invention
|
Humanized and chimeric anti-properdin antibodies. An isolated anti -properdin antibody or antigen... |
|
|
Invention
|
A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies tha... |
|
2010
|
Invention
|
Methods and compositions for inhibiting cellular proliferation and surgical adhesion. A method fo... |
|
2009
|
Invention
|
Method of treating ischemia reperfusion injury.
A method of treating an ischemic reperfusion inj... |
|
|
Invention
|
Method of treating ischemia reperfusion injury. A method of treating an ischemic reperfusion inju... |
|
|
Invention
|
Device and method for inhibiting complement activation.
An extracorporeal device for inhibiting ... |
|
|
Invention
|
Method for treating inflammatory conditions. A method for treating an autoimmune disease in a sub... |
|
2008
|
Invention
|
Inhibition of complement and cellular activation.
A method of inhibiting Fc mediated platelet ac... |
|
|
Invention
|
Method of inhibiting complement activation with factor bb specific antibodies. A process of inhib... |
|
|
Invention
|
Methods of treating inflammatory conditions with adrenergic antagonists.
A method of treating in... |
|
2007
|
Invention
|
Method of inhibiting coagulation activation with human anti-factor va antibodies and use thereof.... |
